Carolinas Wealth Consulting’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5
Closed -$303 453
2025
Q1
$303 Hold
5
﹤0.01% 992
2024
Q4
$346 Hold
5
﹤0.01% 1030
2024
Q3
$331 Buy
+5
New +$319 ﹤0.01% 1032
2023
Q3
Sell
-4
Closed -$249 1064
2023
Q2
$249 Hold
4
﹤0.01% 1044
2023
Q1
$289 Hold
4
﹤0.01% 1044
2022
Q4
$321 Hold
4
﹤0.01% 1040
2022
Q3
$0 Hold
4
﹤0.01% 905
2022
Q2
$0 Hold
4
﹤0.01% 919
2022
Q1
$0 Hold
4
﹤0.01% 959
2021
Q4
$0 Hold
4
﹤0.01% 989
2021
Q3
$0 Hold
4
﹤0.01% 959
2021
Q2
$0 Hold
4
﹤0.01% 966
2021
Q1
$0 Hold
4
﹤0.01% 965
2020
Q4
$0 Hold
4
﹤0.01% 936
2020
Q3
$0 Hold
4
﹤0.01% 967
2020
Q2
$0 Buy
+4
New +$386 ﹤0.01% 688

Other funds holding INCY

Carolinas Wealth Consulting's INCY Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Incyte (INCY) in Q2 2025, closing a stake of 5 shares — an estimated $303 sold.

Carolinas Wealth Consulting first reported a position in INCY in Q2 2020 and held it in 16 quarters. The position peaked at $346 in Q4 2024. 658 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 5 Incyte shares in Q2 2025, an estimated $303.
  • Carolinas Wealth Consulting first reported a position in Incyte in Q2 2020 and held it in 16 quarters.
  • Carolinas Wealth Consulting's Incyte position peaked at $346 in Q4 2024.
  • 658 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.